Detalles de la búsqueda
1.
Comparison of minimal residual disease measurement by multicolour flow cytometry and PCR for fusion gene transcripts in infants with acute lymphoblastic leukaemia with KMT2A gene rearrangements.
Br J Haematol
; 201(3): 510-519, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34970734
2.
Incidence and prognostic value of central nervous system involvement in infants with B-cell precursor acute lymphoblastic leukemia treated according to the MLL-Baby protocol.
Pediatr Blood Cancer
; 69(9): e29860, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35713168
3.
Prognostic value of minimal residual disease measured by fusion-gene transcript in infants with KMT2A-rearranged acute lymphoblastic leukaemia treated according to the MLL-Baby protocol.
Br J Haematol
; 193(6): 1151-1156, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33583020
4.
Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non-high-risk acute lymphoblastic leukemia treated according to the ALL-MB 2008 protocol.
Cancer Med
; 13(8): e7172, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38651186
5.
Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial.
Leukemia
; 37(11): 2276-2281, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37741948
6.
Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report.
Leuk Res
; 112: 106758, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34864370
Resultados
1 -
6
de 6
1
Próxima >
>>